Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)

Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed

(2013) Stefano Ferrari et al.   Journal of Translational Medicine

A Survey on Data Reproducibility in Cancer Research Provides Insights into Our Limited Ability to Translate Findings from the Laboratory to the Clinic

(2013) Aaron Mobley et al.   PLoS One

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

(2012) Stefano Ferrari et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma

(2011) Sigbjørn Smeland et al.   Acta Orthopaedica

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

(2011) J. S. Whelan et al.   ANNALS OF ONCOLOGY

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

(2011) Jakob K. Anninga et al.   EUROPEAN JOURNAL OF CANCER

Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009

(2009) F. Stiefel et al.   ANNALS OF ONCOLOGY

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

(2008) Paul A. Meyers et al.   JOURNAL OF CLINICAL ONCOLOGY